Greg Carter develops computational methods to analyze genetic architecture, design translatable studies of model systems, perform data alignment to precisely quantify disease relevance, and share data through open science platforms. His primary focus is leveraging genetic and genomic data to identify and test potential treatments for Alzheimer’s disease.
